U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C25H19NO3
Molecular Weight 381.4233
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FENDOSAL

SMILES

OC(=O)C1=C(O)C=CC(=C1)N2C(=CC3=C2CCC4=CC=CC=C34)C5=CC=CC=C5

InChI

InChIKey=HAWWPSYXSLJRBO-UHFFFAOYSA-N
InChI=1S/C25H19NO3/c27-24-13-11-18(14-21(24)25(28)29)26-22-12-10-16-6-4-5-9-19(16)20(22)15-23(26)17-7-2-1-3-8-17/h1-9,11,13-15,27H,10,12H2,(H,28,29)

HIDE SMILES / InChI

Molecular Formula C25H19NO3
Molecular Weight 381.4233
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Fendosal (HP 129) is a benzoindole that is 4,5-dihydro-3H-benzo[e]indole in which the nitrogen is substituted by a 3-carboxy-4-hydroxyphenyl group. Fendosal is one of a series of potent non-steroidal anti-inflammatory agents. A non-narcotic analgesic and non-steroidal anti-inflammatory drug, it has greater analgesic and inflammatory responses than aspirin but with less gastrointestinal toxicity. Fendosal 400 mg appears to provide analgesia similar to that of aspirin 650 mg but with a substantially longer duration. Only a few mild side effects were reported.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
36.0 µM [IC50]
PubMed

PubMed

TitleDatePubMed
Design, synthesis, and biological evaluation of N-carboxyphenylpyrrole derivatives as potent HIV fusion inhibitors targeting gp41.
2008 Dec 25
Patents

Sample Use Guides

The purpose of this study was to characterize the analgesic dose-effect curve of orally administered fendosal, relative to aspirin 650 mg and placebo. A total of 153 patients experiencing moderate to severe pain due to extraction of impacted molar teeth completed this two-part, single-dose, double-blind, randomized trial. In part I, the possible treatments were placebo, aspirin 650 mg, fendosal 100 mg and fendosal 200 mg. In part II, fendosal 400 mg replaced the fendosal 100 mg treatment. Fendosal 100 mg was not an analgesic dose but 200 and 400 mg were on the ascending portion of the dose-effect curve. Fendosal 200 mg was superior to placebo and about equal to aspirin in total effect but not peak effect. Fendosal 400 mg was statistically superior to both fendosal 200 mg and placebo. Fendosal 400 mg appears to provide analgesia similar to that of aspirin 650 mg but with a substantially longer duration.
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:14:13 UTC 2023
Edited
by admin
on Fri Dec 15 15:14:13 UTC 2023
Record UNII
9Z709558TZ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FENDOSAL
INN   MI   USAN  
USAN   INN  
Official Name English
FENDOSAL [USAN]
Common Name English
P-71-0129
Code English
FENDOSAL [MI]
Common Name English
P 71-0129
Code English
BENZOIC ACID, 5-(4,5-DIHYDRO-2-PHENYL-3H-BENZ(E)INDOL-3-YL)-2-HYDROXY-
Common Name English
5-(4,5-Dihydro-2-phenyl-3H-benz[E]indol-3-yl)salicylic acid
Systematic Name English
NSC-351522
Code English
fendosal [INN]
Common Name English
ALNOVIN
Brand Name English
Classification Tree Code System Code
NCI_THESAURUS C257
Created by admin on Fri Dec 15 15:14:13 UTC 2023 , Edited by admin on Fri Dec 15 15:14:13 UTC 2023
Code System Code Type Description
PUBCHEM
40821
Created by admin on Fri Dec 15 15:14:13 UTC 2023 , Edited by admin on Fri Dec 15 15:14:13 UTC 2023
PRIMARY
ChEMBL
CHEMBL2106146
Created by admin on Fri Dec 15 15:14:13 UTC 2023 , Edited by admin on Fri Dec 15 15:14:13 UTC 2023
PRIMARY
EVMPD
SUB07555MIG
Created by admin on Fri Dec 15 15:14:13 UTC 2023 , Edited by admin on Fri Dec 15 15:14:13 UTC 2023
PRIMARY
INN
3965
Created by admin on Fri Dec 15 15:14:13 UTC 2023 , Edited by admin on Fri Dec 15 15:14:13 UTC 2023
PRIMARY
CAS
53597-27-6
Created by admin on Fri Dec 15 15:14:13 UTC 2023 , Edited by admin on Fri Dec 15 15:14:13 UTC 2023
PRIMARY
MERCK INDEX
m1158
Created by admin on Fri Dec 15 15:14:13 UTC 2023 , Edited by admin on Fri Dec 15 15:14:13 UTC 2023
PRIMARY Merck Index
CHEBI
135595
Created by admin on Fri Dec 15 15:14:13 UTC 2023 , Edited by admin on Fri Dec 15 15:14:13 UTC 2023
PRIMARY
EPA CompTox
DTXSID80201811
Created by admin on Fri Dec 15 15:14:13 UTC 2023 , Edited by admin on Fri Dec 15 15:14:13 UTC 2023
PRIMARY
DRUG CENTRAL
3224
Created by admin on Fri Dec 15 15:14:13 UTC 2023 , Edited by admin on Fri Dec 15 15:14:13 UTC 2023
PRIMARY
FDA UNII
9Z709558TZ
Created by admin on Fri Dec 15 15:14:13 UTC 2023 , Edited by admin on Fri Dec 15 15:14:13 UTC 2023
PRIMARY
SMS_ID
100000081270
Created by admin on Fri Dec 15 15:14:13 UTC 2023 , Edited by admin on Fri Dec 15 15:14:13 UTC 2023
PRIMARY
NCI_THESAURUS
C80549
Created by admin on Fri Dec 15 15:14:13 UTC 2023 , Edited by admin on Fri Dec 15 15:14:13 UTC 2023
PRIMARY
NSC
351522
Created by admin on Fri Dec 15 15:14:13 UTC 2023 , Edited by admin on Fri Dec 15 15:14:13 UTC 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY